Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.03.11.711130

Hybrid eTFCE-GRF: Exact Cluster-Size Retrieval with Analytical p-Values for Voxel-Based Morphometry

Abstract

Threshold-free cluster enhancement (TFCE) improves sensitivity in voxel-wise neuroimaging inference by integrating cluster extent across all thresholds, but its reliance on permutation testing makes it prohibitively slow for large datasets. Probabilistic TFCE (pTFCE) replaces permutations with analytical Gaussian random field (GRF) p-values, which reduces runtime by more than an order of magnitude, yet relies on a fixed threshold grid that introduces discretisation error. Exact TFCE (eTFCE) eliminates this discretisation by computing the integral exactly via a union-find data structure, but still requires permutations for inference. We propose a hybrid method that combines eTFCEs union-find data structure for exact cluster-size retrieval with pTFCEs analytical GRF inference. The union-find builds the full cluster hierarchy in a single pass over sorted voxels and enables exact cluster-size queries at any threshold in near-constant time; GRF theory then converts these sizes into analytical p-values without permutations. We validate the method through a six-experiment Monte Carlo study on synthetic phantoms (643, 80 subjects): null family-wise error rate is controlled at the nominal level (0/200 rejections, 95% CI [0.0%, 1.9%]); power curves match baseline pTFCE (Dice [≥] 0.999 at sufficient signal); smoothness estimation error is below 1%; and cross-variant concordance exceeds r = 0.99. On real brain data from UK Biobank (N = 500, within-vendor) and IXI (N = 563, cross-vendor), the method detects biologically plausible scanner, age, and sex effects; on IXI, significance maps form strict subsets of the reference R pTFCE output, which supports conservative family-wise error control. Both methods are implemented in pytfce, a pure-Python package with no R or FSL dependencies, available on PyPI. The baseline reimplementation completes whole-brain voxel-based morphometry in [~] 5 s (75 x faster than R pTFCE), while the hybrid variant completes in [~] 85 s (4.6 x faster) with the advantage of exact cluster-size retrieval; both are more than three orders of magnitude faster than permutation-based TFCE. HighlightsO_LIHybrid eTFCE-GRF: exact cluster-size retrieval with analytical inference C_LIO_LIFWER controlled at nominal level in Monte Carlo validation C_LIO_LIpytfce package 4.6 x (hybrid) to 75 x (baseline) faster than R pTFCE C_LIO_LIValidated on UK Biobank (N = 500) and IXI (N = 563) C_LIO_LIOpen-source Python package: pip install pytfce C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yin, D., Chen, H., Miki, T., Liu, B., Yang, E.. 2026-03-13. Hybrid eTFCE-GRF: Exact Cluster-Size Retrieval with Analytical p-Values for Voxel-Based Morphometry. https://doi.org/10.64898/2026.03.11.711130

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗